About ideagaston.eu
Our Mission
Dedicated to advancing interventional oncology and prioritizing patient well-being, our group specializes in early drug development, biomarkers such as liquid biopsies, and metabolic imaging.
Through extensive research projects, we have been involved in over 200 clinical trials, including 19 investigator-sponsored trials.
Our commitment to advancing knowledge in the field is evident through extensive publications in peer-reviewed journals, international conference presentations, and contributions to educational programs. We strive to foster collaboration and innovation within the oncology community, nationally and internationally.